Brainomix announced today that it entered into a strategic partnership with the Medtronic Neurovascular business unit.

J&J has already bought cardiovascular companies Abiomed and Laminar for $16.6bn and $400m · Medical Device Network · Michael Vi / Shutterstock. The neurovascular market, estimated at $4.2bn in ...

J&J’s potential exit from the neurovascular market follows a trend among medtech leaders such as Medtronic and Stryker. Credit: Michael Vi / Shutterstock. The Financial Times recently reported that ...

The common clue to your risk of Alzheimer’s just discovered by scientists - Findings may lead to ‘non-invasive and ...

Measuring variations in the brain’s respiration patterns could help detect Alzheimer ’s disease early, according to a new ...

Managing high blood pressure (hypertension) could lead to a reduced risk of dementia- the loss of cognitive functioning, ...

THE way you breathe may hold clues about your risk of developing Alzheimer’s disease, scientists have found. The discovery ...

Citi’s 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 12:15 PM ETCompany ParticipantsPreston Wells ...